BMRN vs CLOV
Biomarin Pharmaceutical Inc (BMRN) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BMRN and CLOV stock pages for the full models.
Not investment advice.